BioSpace News Archive

Bio NC

Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th

Heat Biologics, Inc. today announced that Jeff Wolf, Chief Executive Officer of Heat Biologics, will be presenting at the Cantor Fitzgerald Global Healthcare Conference being held virtually between September 27-30, 2021.

September 15, 2021
·
1 min read
Drug Development

GammaDelta Therapeutics Initiates First-in-Human Phase 1 Trial of GDX012 for the Treatment of Acute Myeloid Leukaemia

GammaDelta Therapeutics Ltd. today announced that it has initiated a first-in-human Phase I clinical trial evaluating GDX012 for the treatment of acute myeloid leukaemia (AML)

September 15, 2021
·
3 min read
ProMIS Neurosciences to Present at the Second Annual Undruggable Leaders Forum, September 15-16, 2021

ProMIS Neurosciences, Inc. announced today its participation in the Second Annual Undruggable Leaders Forum, a virtual event to be held on September 15-16.

September 15, 2021
·
3 min read
BioCapital

OpGen Announces Data from Prospective Randomized Controlled Multicenter Clinical Study Using the Unyvero HPN Panel for Hospitalized Patients with Suspicion of Pneumonia

OpGen, Inc. today announced clinical data from an investigator-initiated and driven prospective randomized controlled multicenter study.

September 15, 2021
·
7 min read
Biotech Bay

Revolution Medicines to Participate in 3rd Annual RAS-Targeted Drug Development SummitCompany’s Scientific Leadership to Highlight Key Findings from Ongoing RAS(ON) Inhibitor Programs

Revolution Medicines, Inc. today announced that the company will participate in the upcoming 3rd Annual RAS-Targeted Drug Development Summit being held September 21-23, 2021.

September 15, 2021
·
2 min read
Biotech Beach

Qualigen to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Qualigen Therapeutics, Inc. announced today that CEO and Chairman Michael Poirier will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit September 20-23, 2021.

September 15, 2021
·
4 min read
Pharm Country

Palatin to Present Peptides Platform at the TIDES USA Conference

Palatin Technologies, Inc. today announced a featured speaker presentation and two poster presentations at the upcoming TIDES USA hybrid conference in Boston, Massachusetts on September 20-23, 2021.

September 15, 2021
·
4 min read
FDA

BridgeBio Pharma Receives FDA Fast Track Designation for Investigational Therapy for the Treatment of Limb-girdle Muscular Dystrophy Type 2i (LGMD2i)

BridgeBio today announced that the United States Food and Drug Administration (FDA) granted Fast Track designation for the investigation of BBP-418 as a treatment option for Limb-girdle Muscular Dystrophy Type 2i (LGMD2i).

September 15, 2021
·
8 min read
Rapid Dose Therapeutics and McMaster University Provide COVID-19 Vaccine Research Update Including Significant Achievement of Milestones

Today, Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ) and McMaster University (“ McMaster ”) are reporting a preliminary, yet significant milestone in the investigation of an orally delivered vaccine candidate for COVID-19.

September 15, 2021
·
5 min read
Business

Saniona appoints Wendy Dwyer as Chief Business Officer

Saniona, a clinical stage biopharmaceutical company focused on rare diseases, announced the appointment of Wendy Dwyer as Chief Business Officer.

September 15, 2021
·
3 min read